Age-dependent patterns of infection and severity explaining the low impact of 2009 influenza A (H1N1): Evidence from serial serologic surveys in the Netherlands

American Journal of Epidemiology

Volumn 174, Issue 11, 2011, Pages 1307-1315

  Steens, Anneke ^a   Waaijenborg, Sandra ^a,b   Teunis, Peter F M ^a,c   Reimerink, Johan H J ^a   Meijer, Adam ^a   Van Der Lubben, Mariken ^a   Koopmans, Marion ^a,d   Van Der Sande, Marianne A B ^a,b   Wallinga, Jacco ^a,b   Van Boven, Michiel ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c EMORY UNIVERSITY   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Disease outbreaks; Disease transmission, infectious; Influenza A virus, H1N1 subtype; Influenza, human; Serology

Indexed keywords

AGE CLASS; AGE-RELATED DIFFERENCE; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DISEASE SEVERITY; DISEASE SPREAD; DISEASE TREATMENT; EPIDEMIC; INFECTIOUS DISEASE; INFLUENZA; MORTALITY; PUBLIC HEALTH; QUESTIONNAIRE SURVEY; SERUM; SPATIOTEMPORAL ANALYSIS; SUBPOPULATION;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CHILD; DISEASE SEVERITY; DISEASE TRANSMISSION; FLU LIKE SYNDROME; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; NETHERLANDS; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; AGE; EPIDEMIOLOGY; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED;

NETHERLANDS;

INFLUENZA A VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; NETHERLANDS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84856059616     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr245     Document Type: Article

References (38)

1. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. WHO Rapid Pandemic Assessment Collaboration. Science. 2009;324(5934):1557-1561.
2. Van Kerkhove MD, Asikainen T, Becker NG, et al. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med. 2010;7(6):e1000275. (doi:10.1371/journal.pmed. 1000275).
3. Leung GM, Nicoll A. Reflections on pandemic (H1N1) 2009 and the international response. PLoS Med. 2010;7(10):e1000346. (doi:10.1371/journal. pmed.1000346).
4. Presanis AM, De Angelis D, Hagy A, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. New York City Swine Flu Investigation Team. PLoS Med. 2009;6(12):e1000207. (doi:10.1371/journal.pmed.1000207).
5. Chen MI, Lee VJ, Lim WY, et al. 2009 influenza A (H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA. 2010;303(14):1383-1391.
6. Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a crosssectional serological study. Lancet. 2010;375(9720):1100-1108.
7. Allwinn R, Geiler J, Berger A, et al. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol. 2010;199(2):117-121.
8. Zimmer SM, Crevar CJ, Carter DM, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One. 2010;5(7):e11601. (doi:10.1371/journal.pone.0011601).
9. Adamson WE, Maddi S, Robertson C, et al. 2009 pandemic influenza A (H1N1) virus in Scotland: geographically variable immunity in spring 2010, following the winter outbreak. Euro Surveill. 2010;15(24):19590.
10. Waalen K, Kilander A, Dudman SG, et al. High prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill. 2010;15(31):19633.
11. Grills N, Piers LS, Barr I, et al. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009. Aust N Z J Public Health. 2010;34(3):228-231.
12. Gilbert GL, Cretikos MA, Hueston L, et al. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 Southern Hemisphere winter. PLoS One. 2010;5(9):e12562. (doi:10.1371/journal.pone.0012562).
13. Tandale BV, Pawar SD, Gurav YK, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis. 2010;10:255. (doi:10.1186/1471-2334-10-255).
14. Deng Y, Pang XH, Yang P, et al. Serological survey of 2009 H1N1 influenza in residents of Beijing, China. Epidemiol Infect. 2011;139(1):52-58.
15. Wu JT, Ma ES, Lee CK, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis. 2010;51(10):1184- 1191.
16. McVernon J, Laurie K, Nolan T, et al. Seroprevalence of 2009 pandemic influenza A (H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill. 2010;15(40):19678.
17. Bandaranayake D, Huang QS, Bissielo A, et al. Risk factors and immunity in a nationally representative population following the 2009 influenza A (H1N1) pandemic. 2009 H1N1 Serosurvey Investigation Team. PLoS One. 2010;5(10):e13211. (doi:10.1371/journal.pone.0013211).
18. World Health Organization. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2010;85(24):229-235.
19. Skowronski DM, Hottes TS, Janjua NZ, et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ. 2010;182(17):1851-1856.
20. Forster JJ. Sample surveys: nonprobability sampling. In: Smelser NJ, Wright J, Baltes PB, eds. International Encyclopedia of the Social and Behavioral Sciences. New York, NY: Elsevier, Inc; 2001:13467-13470.
21. Donker GA. Continuous Morbidity Registration at Dutch Sentinel General Practice Network 2009 (in Dutch). Utrecht, the Netherlands: Netherlands Institute for Health Services Research (NIVEL); 2011.
22. National Institute for Biological Standards and Control, United Kingdom Health Protection Agency. Influenza Reagent Candidate International Standard for Antibody to Influenza H1N1pdm Virus. (NIBSC code 09/194. Version 2.0, dated July 4, 2010). Ridge, United Kingdom: National Institute for Biological Standards and Control; 2010.
23. Hahné S, Donker T, Meijer A, et al. Epidemiology and control of influenza A (H1N1) v in the Netherlands: the first 115 cases. Dutch New Influenza A (H1N1) v Investigation Team. Euro Surveill. 2009;14(27):19267.
24. Baguelin M, Hoschler K, Stanford E, et al. Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihoodbased estimation. PLoS One. 2011;6(2):e17074. (doi:10.1371/journal.pone.0017074).
25. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis. 2010;51(12):1370-1379.
26. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460(7258):1021-1025.
27. Munster VJ, de Wit E, van den Brand JM, et al. Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets. Science. 2009;325(5939):481-483.
28. Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53-60. (Pubitemid 28328076)
29. Brundage JF. Cases and deaths during influenza pandemics in the United States. Am J Prev Med. 2006;31(3):252-256. (Pubitemid 44176302)
30. Hadler JL, Konty K, McVeigh KH, et al. Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May-June 2009. PLoS One. 2010;5(7):e11677. (doi:10.1371/journal.pone. 0011677).
31. Dawood FS, Hope KG, Durrheim DN, et al. Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England. Northern New South Wales, Australia, 2009. PLoS One. 2010;5(3):e9880. (doi:10.1371/journal.pone. 0009880).
32. Tacken M, Mulder J, van den Hoogen H, et al. Monitoring National Influenza Prevention Program 2008 (in Dutch). Nijmegen, the Netherlands: Netherlands Information Network of General Practice (LINH); 2009.
33. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol. 2006;164(10):936-944. (Pubitemid 44729833)
34. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74. (doi:10.1371/journal.pmed.0050074). (Pubitemid 351471689)
35. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945-1952.
36. van Boven M, Donker T, van der Lubben M, et al. Transmission of novel influenza A (H1N1) in households with post-exposure antiviral prophylaxis. PLoS One. 2010;5(7):e11442. (doi:10.1371/journal.pone.0011442).
37. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med. 2009;361(27):2619-2627.
38. Wallinga J, van Boven M, Lipsitch M. Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci U S A. 2010;107(2):923-928.